HOME | CONTACT US | LOGIN | REGISTER
 
PRESS RELEASE
   2010
 2009
 2008
 2007
 2006
Generex in the PRESS
2008 Press Release

Needle-Free Generex Oral-lyn(tm) Approved by Lebanese Ministry of Public Health for Diabetes Manage
  December 23, 2008
   
Generex Biotechnology and Pevion Biotech Announce Plans for Immunotherapeutic Vaccine Collaboration
  December 16, 2008
   
Generex Awarded New Patent in Europe
  December 15, 2008
   
GENEREX BIOTECHNOLOGY UPDATE ON NOVEL IMMUNOTHERAPEUTIC VACCINE TO BE PRESENTED AT SAN ANTONIO BREA
  December 11, 2008
   
Generex Announces Positive Results of Metformin Chewing Gum Trial
  December 02, 2008
   
Generex Updates on Press Coverage of Generex Oral-lynTM Commercial Launch in India
  November 25, 2008
   
Generex Awarded New Pain Relief Patents
  November 19, 2008
   
Generex Launches Oral Insulin for Diabetes Management in India; Retail Availability Coincides with W
  November 14, 2008
   
Generex Biotechnology to Make Convertible Debenture Payment in Cash Company foregoes issuing equity
  November 12, 2008
   
Generex Biotechnology Corporation’s Antigen Express Subsidiary featured in Technology Update and V
  November 10, 2008
   
Generex Biotechnology Submits Syrian Dossier
  November 05, 2008
   
Generex Oral-lyn(tm) Featured On XM Satellite Radio
  November 05, 2008
   
Generex Oral-lyn™ Featured on XM Satellite Radio
  November 05, 2008
   
Generex Oral-lyn Featured at International Diabetes Conference
  November 04, 2008
   
Generex Biotechnology Comments On New ADA/EASD Consensus Algorithm for Type 2 Diabetes Treatment
  October 30, 2008
   
Generex to Host Satellite Symposium At World Congress on Controversies to Consensus in Diabetes, Obe
  October 29, 2008
   
Generex Biotechnology Awarded New Drug Delivery Patent
  October 27, 2008
   
Generex Biotechnology Granted Additional Time to Comply With Nasdaq Marketplace Rule 4310(c)(4)
  October 23, 2008
   
Generex Announces Enrollment of Initial Subjects in Metformin Gum Trial
  October 16, 2008
   
Generex Biotechnology to Present at 2008 BioNetwork Conference
  October 07, 2008
   
Generex Biotechnology to Present At 2008 BioNetwork Conference
  October 07, 2008
   
Generex Biotechnology Corp. Announces Cancelled Trades
  October 01, 2008
   
Generex Announces Enrollment of More Than Two Hundred Subjects in Generex Oral-lyn Phase III Trial
  September 16, 2008
   
Generex Biotechnology To Present Abstracts At Scientific Symposium 44th Annual Meeting of the Europe
  September 05, 2008
   
Generex Biotechnology to Sponsor International Diabetes Symposium in Rome
  September 04, 2008
   
Generex Biotechnology Signs Oral Insulin Distribution Deal for Korea
  August 25, 2008
   
Generex Biotechnology Inks Glucose RapidSpray Distribution Deal in Brazil
  August 21, 2008
   
Crystal Research Associates, LLC Issues Executive Informational Overview
  August 20, 2008
   
Generex Announces Enrollment of Over 150 Patients In Phase III Trial of Generex Oral-lyn
  August 12, 2008
   
Enrollment of breast and ovarian cancer patients commenced for combination therapy trial to include
  August 07, 2008
   
Generex Biotechnology to Commence Generex Oral-lyn™ Trial Involving Subjects With Impaired Glucose
  August 05, 2008
   
Initiation Coverage Review Issued By Scimitar Equity, LLC
  July 30, 2008
   
Generex Biotechnology Featured on FOXNews.com
  July 23, 2008
   
Generex Biotechnology Sponsors Generex Oral-lyn™ Education & Training Symposium in Middle East Sym
  July 17, 2008
   
Generex Biotechnology Generates New Sales of Approximately $300,000 through the Generex MENA Office
  July 16, 2008
   
Generex To Present Data at Controlled Release Society Annual Meeting
  July 10, 2008
   
Investigational New Drug Application Submitted On Behalf Of Generex Biotechnology For Combination Im
  July 09, 2008
   
Generex Provides Update on Dosing of Patients In Phase III Trial of Generex Oral-lyn™
  July 08, 2008
   
Generex Biotechnology Expands Mayo Clinic
  June 26, 2008
   
Generex Biotechnology Presented Data at The Endocrine Society’s Annual Meeting
  June 19, 2008
   
Generex Biotechnology Corporation to Hold Conference Call on Tuesday, June 24th to Update Investors
  June 18, 2008
   
Generex Biotechnology Corporation to Hold Conference Call on Tuesday, June 24th to Update Investors
  June 18, 2008
   
Generex Biotechnology Presented Data At the American Diabetes Association Scientific Sessions
  June 09, 2008
   
Generex Biotechnology Presented Data At American Diabetes Association Scientific Sessions
  June 09, 2008
   
Generex Biotechnology offers New Hope in Management of Diabetes
  June 09, 2008
   
ADA's 68th Scientific Sessions: A New Look at Insulin Therapy - Seeking Alpha
  June 09, 2008
   
Generex Biotechnology Commences Patient Dosing For Pivotal Phase III Trial of Generex Oral-lyn
  June 05, 2008
   
Generex Biotechnology Phase I Trial Results for Novel Immunotherapy Vaccine in Breast Cancer Patient
  June 03, 2008
   
Generex Biotechnology to Make Podium Presentations of Data At the 68th Annual American Diabetes Asso
  June 02, 2008
   
Generex Establishes Branch Office
  May 27, 2008
   
Generex Biotechnology Announces That It Has Produced MetControl, the Company's Proprietary Metformin
  May 26, 2008
   
Generex Biotechnology Announces That It Has Produced MetControl, the Company's Proprietary Metformin
  May 12, 2008
   
PRIVATE PLACEMENT LEADING DEALS
  May 10, 2008
   
Generex Study Proposes Increased Reporting of Clinical Outcomes to Support Reimbursement of Non-Inje
  May 07, 2008
   
Generex Biotechnology Announces North American Initiation of Generex Oral-lyn Phase III Diabetes Stu
  April 07, 2008
   
Generex Biotechnology Raises $20,650,000 Through Private Placement
  April 01, 2008
   
Generex Biotechnology to Issue Notes
  April 01, 2008
   
Generex Biotechnology and SciGen, Ltd. Enter Into Distribution Agreement for Generex Oral-lyn in Chi
  April 01, 2008
   
Generex Biotechnology Receives Indian Purchase Order for Generex Oral-lyn
  March 25, 2008
   
Generex Biotechnology Clarifies Stance of Medical Affairs VP
  March 20, 2008
   
Generex Biotechnology Announces That Its Protocol for Metcontrol, the Company's Proprietary Metformi
  March 12, 2008
   
Generex Biotechnology Announces That Supplies for a Phase III Study of Generex Oral-lyn for a Number
  March 11, 2008
   
Generex Biotechnology Comments On Recent Trading Activity
  March 10, 2008
   
Generex Biotechnology to Make Presentations At International Conference On Hypertension, Lipids, Dia
  March 06, 2008
   
Generex Biotechnology Awarded Patents
  March 04, 2008
   
Generex Biotechnology Extends Clinical Trial Agreement for Testing its Synthetic Avian Influenza Vac
  March 03, 2008
   
Generex Biotechnology announces that an Investigators’ meeting was recently held for its global Ph
  February 04, 2008
   
Generex Biotechnology Awarded New European Patent
  January 29, 2008
   
Generex Biotechnology Receives Regulatory Approval to Initiate Phase III Clinical Trial for Generex
  January 23, 2008
   
Generex Biotechnology Announces Co-Authorship of Publications With Johns Hopkins University and Stal
  January 22, 2008
   
Generex Biotechnology Announces Generex Oral-lyn Marketing Launch Activities Made by the Company's M
  January 17, 2008
   
Generex Biotechnology Announces Participation At 2008 Arab Health Congress Together With Middle East
  January 15, 2008